Abstract
The genome of hepatitis B virus (HBV) is a partially double-stranded DNA molecule within virus particles that is approx 3.2 kbp long (1,2). It has four open reading frames, all on one strand, that encode the surface antigen or envelope polypeptides, core or nucleocapsid polypeptide, the viral polymerase, and the so-called “X” protein (1,2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., and Charnay, P. (1979) Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281, 646–650.
Valenzuela, P., Quiroga, M., Zaldivar, J., Gray, P., and Rutter, W. J. (1980) The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In: Fields, B. N., Jaenisch, R., and Fox, C. F. (eds.), Animal Virus Genetics, Academic Press, New York, 57–70.
Bayer, M. E., Blumberg, B. S., and Werner, B. (1968) Particles associated with Australia antigen in sera of patients with leukemia, Down’s syndrome and hepatitis. Nature 218, 1057–1059.
Dane, D. S., Cameron, C. H., and Briggs, M. (1970) Virus-like particles in serum of patients with Australia antigen-associated hepatitis. Lancet 2, 695–698.
Almeida, J. D., Rubenstein, D., and Stott, E. J. (1971) New antigen-antibody system in Australia antigen-positive hepatitis. Lancet 2, 1225–1227.
Budkowska, A. (1977) Immunochemical and morphological studies of hepatitis B core antigen isolated from the nuclei of hepatocytes. J. Infect. Dis. 135, 463–467.
Maynard, J. E., Barret, D. H., Murphy, B. L., Bradley, D. W., Berquist, K. R., and Bender T. R. (1976) Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity. J. Infect. Dis. 133, 339–342.
Okado, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., and Mayumi, M. (1976) e Antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N. Engl. J. Med. 294, 746–749.
Bavand, M., Feitelson, M., and Laub, O. (1989) The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene. J. Virol. 63, 1019–1021.
Oberhaus, S. M., and Newbold, J. E. (1993) Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J. Virol. 67, 6558–6566.
Radziwill, G., Tucker, W., and Schaller, H. (1990) Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64, 613–620.
Summers, J., and Mason, W. (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29, 403–415.
Bartenschlager, R., and Schaller, H. (1988) The amino-terminal domain of the hepadnavirus P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J. 7, 4185–4192.
Rossner, M. T. (1992) Hepatitis B virus X-gene product: a promiscuous transcriptional activator. J. Med. Virol. 36, 101–117.
Nakatake, H., Chisaka, O., Yamamoto, S., Matsubara, K., and Koshy, R. (1993) Effect of X protein on transactivation of HBV promoters and on viral replication. Virology 195, 305–314.
Colgrove, R., Simon, G., and Ganem, D. (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol. 63, 4019–4026.
Chen, H. S., Kaneko, S., Girones, R., et al. (1993) The WHV X gene is important for establishment of virus infection in woodchucks. J. Virol. 67, 1218–1226.
Zoulim, F., Saputelli, J., and Seeger, C. (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68, 2026–2030.
Henkler, F., and Koshy, R. (1996) Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J. Vi ral Hepat. 3, 109–121.
Arbuthnot, P., Capovilla, A., and Kew, M. (2000) Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J. Gastroenterol. Hepatol. 15, 357–368.
Beasley, R. P., Hwang, L. Y., Lin, C. C., and Chien, C. S. (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2, 1129–1133.
Beasley, R. P., and Hwang, L. Y. (1994) Epidemiology of hepatocellular carcinoma. In: Vyas, G. N., Dienstag, J. L., and Hoofnagle, J. H. (eds.), Viral Hepatitis and Liver Disease, Grune and Stratton, New York, 209–224.
Maddrey, W. C. (2001) Hepatitis B—an important public health issue. Clinica y Laboratorio 47, 51–55.
Lok, A. S., Heathcote, E. J., and Hoofnagle, J. H. (2001) Management of hepatitis B: 2000—summary of a workshop. Gastroenterology 120, 1828–1853.
Hilleman, M. R. (2001) Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications. Vaccine 19, 1837–1848.
Moriarty, A. M., Alexander, H., and Lerner, R. A. (1985) Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227, 429–433.
Schek, N., Bartenschlager, R., Kuhn, C., and Schaller, H. (1991) Phosphorylation and rapid turnover of hepatitis B virus X protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 6, 1735–1744.
Levrero, M., Jean-Jean, O., Balsano, C., Will, H., and Perricaudet, M. (1990) Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. Virology 174, 299–304.
Ke-qin, H., Jian-jie, H., and Will, H. (1988) A preliminary study on localization of HBxAg in liver tissue of patients with chronic liver disease and its significance. Chinese Med. J. 101, 671–674.
Vitvitski-Trepo, L., Kay, A., Pichoud, C., et al. (1990) Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology 12, 1278–1283.
Levrero, M., Jean-Jean, O., Balsano, C., Will, H., and Perricaudet, M. (1987) Hepatitis B virus (HBV) X gene expression in human cells and anti-x antibodies detection in chronic HBV infection. In: Robinson, W. S., Koike, K., and Will, H. (eds.), Hepadna Viruses, Alan R. Liss, New York, 237–252.
Pfaff, E., Salfeld, J., Gmelin, K., Schaller, H., and Theilmann, L. (1987) Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology 158, 456–460.
Haruna, Y., Hayashi, N., Katayama, K., et al. (1991) Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology 13, 417–421.
Suzuki, K., Uchida, T., Shikata, T., et al. (1990) Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B. Liver 10, 355–364.
Feitelson, M. A., and Clayton, M. M. (1990) The X antigen/antibody markers in hepadnavirus infections. II. Antibodies to the X gene product(s). Gastroenterology 99, 500–507.
Feitelson, M. A., and Clayton, M. M. (1990) X antigen polypeptides in the sera of hepatitis B virus infected patients. Virology 177, 367–371.
Feitelson, M. A., Clayton, M. M., and Blumberg, B. S. (1990) The X antigen/antibody markers in hepadnavirus infections. I. Presence and significance of the hepadnavirus X gene product(s) in serum. Gastroenterology 98, 1071–1078.
Vitvitski, L., Meyers, M. L., Sninsky, J. J., et al. (1988) Expression of the X gene product of hepatitis B virus and WHV in infected livers and transfected 3T3 cells: evidence for cross-reactivity and correlation with core/e gene expression. In: Zuckerman, A. J. (ed.), Vira l Hepatitis and Liver Disease, Alan R. Liss, New York, 341–344.
Katayama, K., Hayashi, N., Sasaki, Y., et al. (1989) Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology 97, 990–998.
Zentgraf, H., Herrmann, G., Klein, R., et al. (1990) Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology 47, 143–148.
Takeuchi, M., Fujimoto, J., Niwamoto, H., Yamamoto, Y., and Okamoto, E. (1997) Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig. Dis. Sci. 42, 2264–2269.
Diamantis, I. D., McGandy, C. E., Chen, T. J., Liaw, Y. F., Gudat, F., and Bianchi, L. (1992) Hepatitis B X-gene expression in hepatocellular carcinoma. J. Hepatol. 15, 400–403.
Poussin, K., Dienes, H., Sirma, H., et al. (1999) Expression of mutated hepatitis B virus X genes in human hepatocellular carcinoma. Int. J. Cancer 80, 497–505.
Schluter, V., Meyer, M., Hofschneider, P. H., Koshy, R., and Caselmann, W. H. (1994) Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene 9, 3335–3344.
Wang, W., London, W. T., Lega, L., and Feitelson, M. A. (1991) Hepatitis B x antigen in liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14, 29–37.
Wang, W., London, W. T., and Feitelson, M. A. (1991) Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 51, 4971–4977.
Feitelson, M. A., Lega, L., Duan, L.-X., and Clayton, M. (1993) Characteristics of wood-chuck hepatitis X antigen in the livers and sera from chronically infected animals. J. Hepatol. 17, S24–S34.
Su, Q., Schroder, C. H., Hofmann, W. J., Otto, G., Pichlmayr, R., and Bannasch, P. (1998) Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27, 1109–1120.
Kim, H., Lee, H., and Yun, Y. (1998) X-gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem. 273, 381–385.
Pollicino, T., Terradillos, O., Lecoeur, H., Gougeon, M. L., and Buendia, M. A. (1998) Pro-apoptotic effect of the hepatitis B virus X gene. Biomed. Pharmacother. 52, 363–368.
Shirakata, Y., Kawada, M., Fujiki, Y., et al. (1989) The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 80, 617–621.
Jameel, S., Siddiqui, A., Maguire, H. F., and Rao, K. V. S. (1990) Hepatitis B virus protein produced in Escherichia coli is biologically functional. J. Virol. 64, 3963–3966.
Takada, S., Kaneniwa, N., Tsuchida, N., and Koike, K. (1997) Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene transfected cells. Oncogene 15, 1895–1901.
Kuzhandaivelu, N., Cong, Y. S., Inouye, C., Yang, W. M., and Seto E. (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res. 24, 4741–4750.
Becker, S. A., Lee, T. H., Butel, J. S., and Slagle, B. L. (1998) Hepatitis B virus protein interferes with cellular DNA repair. J. Virol. 72, 266–272.
Shintani, Y., Yotsuyanagi, H., Moriya, K., et al. (1999) Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J. Gen. Virol. 80, 3257–3265.
Lee, Y. H., and Yun, Y. (1998) HBx protein of hepatitis B virus activates Jak1-STAT signaling. J. Biol. Chem. 273, 25,510–25,515.
Lian, Z., Pan, J., Liu, J., et al. (1999) The translation initiation factor, SUI1, may be a target of hepatitis B x antigen in hepatocarcinogenesis. Oncogene 18, 1677–1687.
Su, F., and Schneider, R. J. (1997) Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 94, 8744–8749.
Blum, H. E., Zhang, Z. S., Galun, E., et al. (1992) Hepatitis B virus X protein is not central to the viral life cycle in vitro. J. Virol. 66, 1223–1227.
Shin, E. C., Shin, J. S., Park, J. H., Kim, H., and Kim, S. J. (1999) Expression of Fas ligand in human hepatoma cell lines: role of hepatitis B virus X (HBx) in induction of Fas ligand. Int. J. Cancer 82, 587–591.
Lara-Pezzi, E., Majano, P. L., Gomez-Gonzalo, M., et al. (1998) The hepatitis B virus X protein up-regulates tumor necrosis factor a gene expression in hepatocytes. Hepatology 28, 1013–1028.
Doong, S. L., Lin, M. H., Tsai, M. M., Li, T. R., Chuang, S. E., and Cheng, A. L. (1998) Transactivation of the human MDR1 gene by hepatitis B virus X gene product. J. Hepatol. 29, 872–878.
Ueda, H., Ullrich, S. J., Ngo, L., et al. (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9, 41–47.
Koike, K, Moriya, K, Iino, S., et al. (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19, 810–819.
Schmitteckert, E. M., and Schlicht, H. J. (1999) Detection of the human hepatitis B virus X-protein in transgenic mice after radioactive labeling at a newly introduced phosphorylation site. J. Gen. Virol. 80, 2501–2509.
Slagle, B. L., Lee, T. H., Medina, D., Finegold, M. J., and Butel, J. S. (1996) Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog. 15, 261–269.
Lee, T. H., Finegold, M. J., Shen, R. F., DeMayo, J. L., Woo, S. L., and Butel, J. S. (1990) Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol. 64, 5939–5947.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Liu, J., Feitelson, M.A. (2004). Detection of Hepatitis B Virus X Antigen by Immunohistochemistry and Western Blotting. In: Hamatake, R.K., Lau, J.Y.N. (eds) Hepatitis B and D Protocols. Methods in Molecular Medicine, vol 95. Humana Press. https://doi.org/10.1385/1-59259-669-X:71
Download citation
DOI: https://doi.org/10.1385/1-59259-669-X:71
Publisher Name: Humana Press
Print ISBN: 978-1-58829-105-9
Online ISBN: 978-1-59259-669-0
eBook Packages: Springer Protocols